Nutrients 2012, 4(12), 1828-1850; doi:10.3390/nu4121828
Review

The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)

Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02215, USA
* Author to whom correspondence should be addressed.
Received: 30 October 2012; in revised form: 11 November 2012 / Accepted: 19 November 2012 / Published: 27 November 2012
(This article belongs to the Special Issue Parenteral Nutrition)
PDF Full-text Download PDF Full-Text [953 KB, uploaded 27 November 2012 11:20 CET]
Abstract: Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged as well as concerns about potential risks with using fish oil as a monotherapy. This review will discuss the experience to date with this lipid emulsion along with the rational for its use, controversies and concerns.
Keywords:  parenteral nutrition; pediatrics; lipid emulsions; intestinal failure-related liver disease; fish oil

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Chang, M.I.; Puder, M.; Gura, K.M. The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD). Nutrients 2012, 4, 1828-1850.

AMA Style

Chang MI, Puder M, Gura KM. The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD). Nutrients. 2012; 4(12):1828-1850.

Chicago/Turabian Style

Chang, Melissa I.; Puder, Mark; Gura, Kathleen M. 2012. "The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)." Nutrients 4, no. 12: 1828-1850.

Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert